Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Sernova Corp T.SVA

Alternate Symbol(s):  SEOVF

Healthcare Biotechnology
Sernova Corp. is a Canada-based clinical-stage biotechnology company, which is developing therapeutic cell technologies for chronic diseases, including insulin-dependent diabetes, thyroid disease, and blood disorders that include hemophilia A. The Company is focused on developing a functional cure for insulin-dependent diabetes with its therapeutic cell technology, the Cell Pouch System, a novel implantable and scalable medical device with immune protected therapeutic cells. The Cell Pouch is a scalable, implantable medical device. The Cell Pouch is designed to create a vascularized organ-like environment for the transplantation and engraftment of therapeutic cells. Its regenerative medicine therapeutic approach is to provide cell therapies where the cells, transplanted within an organ-like vascularized implantable device, the Cell Pouch, generates proteins, hormones or factors released into the bloodstream for treatment of diseases requiring replacement of these molecules in the body.


TSX:SVA - Post by User

Sernova Corp
Bullboard Posts
User Avatar Image
(13)
•••
Comment by fivenineon Apr 22, 2020 2:04pm
119 Views
Post# 30940388

RE:Redbaron2211 please check messages, thank you "AGM"

RE:Redbaron2211 please check messages, thank you "AGM"
jwallisca wrote: Rb2211:

Please check your messages regarding Sernova's AGM at 9:00 AM PDT, 30 April 2020.

I didn't realize how much effort Sernova is putting into having the AGM with this COVID-19 crisis swirling around us all.

So much goes on behind the scenes, which we unsuspecting shareholders have no idea about.

Kudos to Sernova for what it is doing for everyone regarding this AGM.

To those who have not voted, I urge you to do so and, if you have an understanding type heart, please support management. I know it will be appreciated by Sernova more than you might imagine.

jwall


To the portion in red, safe to say this the case for more than just the AGM preparations...would be true for the effort put into this venture day in, day out by the entire Sernova team.
Bullboard Posts
Dealroom for high-potential pre-IPO opportunities